Trial · NCT01227421
Outcomes15
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Time to Resolution of All Clinical Symptoms of Influenza as Reported by the Subjects | Up to 28 days | 624 patients were enrolled based on inclusion/exclusion criteria. The primary efficacy analysis was conducted on the 257 patients with laboratory confirmed influenza. | Hours | MEDIAN |
| SECONDARY | Time to Resolution of Each Individual Symptom of Influenza as Reported by the Subjects | at least 28 days | 624 patients were enrolled based on inclusion/exclusion criteria. Secondary efficacy analyses were conducted on the 257 patients with laboratory confirmed influenza. | Hours | MEDIAN |
| SECONDARY | Mean Change (Standard Deviation)in 50% Tissue Culture Infective Dose (TCID50) Viral Titer From Baseline | 7 days | Analysis conducted on 113 patients from intensive virologic follow up group with laboratory confirmed influenza | LOG10 Titer | MEAN |
| SECONDARY | Mean Change in RT-PCR (Reverse Transcription Polymerase Chain Reaction) Viral Titer From Baseline | 7 days | Analysis conducted on 113 patients from the intensive virologic follow up group with laboratory confirmed influenza | LOG10 RNA copies | MEAN |
| SECONDARY | Time to Cessation of Viral Shedding Measure by 50% Tissue Culture Infective Dose (TCID50) | 28 days | Analysis performed on 107 patients from the intensive virologic follow up population with laboratory confirmed influenza | Hours | MEDIAN |
| SECONDARY | Time to Return to Normal Daily Activities | 28 days | Analysis conducted on 257 patients with laboratory confirmed influenza | Hours | MEDIAN |
| SECONDARY | Symptom Severity Score Hours | 28 days | Analysis conducted for 257 patients with laboratory confirmed influenza | symptom score *hour | MEAN |
| SECONDARY | Time Loss From Work | 28 days | Analysis conducted on 241 patients with laboratory confirmed influenza excluding those who are unemployed | days | MEAN |
| SECONDARY | Complications of Influenza | 28 days | All patients who received at least one dose of study medication | Participants | NUMBER |
| SECONDARY | Influenza Antibody Response Titer Change: Influenza A 2009 H1N1 | 28 days | Member of the intensive virologic follow up group with laboratory confirmed Influenza A 2009 H1N1 | Fold change in antibody titer | MEDIAN |
| SECONDARY | Influenza Antibody Response: Influenza A H3N2 | 28 days | Members of the intensive virologic follow up group with laboratory confirmed influenza A H3N2 | Fold change in antibody titer | MEDIAN |
| SECONDARY | Influenza Antibody Response: Influenza B | 28 days | Members of intensive virologic follow up group with laboratory confirmed Influenza B | Fold change in antibody titer | MEDIAN |
| SECONDARY | Influenza Antibody Response: Seroprotection and Seroconversion for Patients With Influenza A 2009 H1N1 | 28 days | Members of intensive virologic follow up group with laboratory confirmed Influenza A 2009 H1N1 | Participants | NUMBER |
| SECONDARY | Influenza Antibody Response: Seroprotection and Seroconversion for Patients With Influenza A H3N2 | 28 days | Members of intensive virologic follow up group with laboratory confirmed Influenza A H3N2 | Participants | NUMBER |
| SECONDARY | Influenza Antibody Response: Seroprotection and Seroconversion for Influenza B | 28 days | Members of intensive virologic follow up group with laboratory confirmed Influenza B | Participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01227421/outcomes